Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Ipsen Pharma, 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France
NutropinAq 10 mg/2 ml (30 IU) solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear and colourless solution. |
One ml contains 5 mg of somatropin*.
One cartridge contains 10 mg (30 IU) of somatropin.
* Somatropin is a human growth hormone produced in Escherichia coli cells by recombinant DNA technology.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Somatropin |
Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat. |
| List of Excipients |
|---|
|
Sodium chloride |
2 ml of solution in a cartridge (Type I glass) closed with a stopper (butyl rubber) and a seal (rubber).
Pack sizes of 1, 3 and 6 cartridges.
Not all pack sizes may be marketed.
Ipsen Pharma, 65 quai Georges Gorse, 92100 Boulogne-Billancourt, France
EU/1/00/164/003
EU/1/00/164/004
EU/1/00/164/005
Date of first authorisation: 16 February 2001
Date of latest renewal: 16 February 2006
| Drug | Countries | |
|---|---|---|
| NUTROPINAQ | Australia, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
